BRIEF-Roche Diagnostics Says Receives Health Canada Authorization To Market Cobas Hpv On Cobas 6800/8800 Systems For Cervical Cancer Screening In Canada
1 Min Read
Jan 31 (Reuters) - Roche Holding AG:
* ROCHE DIAGNOSTICS - RECEIVES HEALTH CANADA AUTHORIZATION TO MARKET COBAS HPV ON COBAS 6800/8800 SYSTEMS FOR CERVICAL CANCER SCREENING IN CANADA. Source text for Eikon: Further company coverage: